C5b-9 Membrane Attack Complex Mediates Endothelial Cell Apoptosis in Experimental Glomerulonephritis
Overview
Physiology
Affiliations
We studied the role of the C5b-9 membrane attack complex in two models of inflammatory glomerulonephritis (GN) initiated by acute glomerular endothelial injury in Piebold-viral-Glaxo (PVG) complement-sufficient rats (C+), C6-deficient rats (C6-), and rats systematically depleted of complement with cobra venom factor (CVF). GN was induced by performing a left nephrectomy and selectively perfusing the right kidney with either 1) the lectin concanavalin A (Con A) followed by complement-fixing anti-Con A (Con A GN) or 2) purified complement-fixing goat anti-rat glomerular endothelial cell (GEN) antibody [immune-mediated thrombotic microangiopathy (ITM)]. Comparable levels of GEN apoptosis were detected in C+ animals in both models. CVF administration reduced GEN apoptosis by 10- to 12-fold. GEN apoptosis was C5b-9 dependent because PVG C6- rats were protected from GEN loss. Furthermore, functional inhibition of the cell surface complement regulatory protein CD59 by renal perfusion with anti-CD59 antibody in ITM resulted in a 3.5-fold increase in GEN apoptosis. Last, in Con A GN, abrogation of GEN apoptosis preserved endothelial integrity and renal function. This study demonstrates the specific role of C5b-9 in the induction of GEN apoptosis in experimental inflammatory GN, a finding with implications for diseases associated with the presence of antiendothelial cell antibodies.
Lin J, Hwang S, Luo H, Mohamud Y Biology (Basel). 2024; 13(6).
PMID: 38927311 PMC: 11200454. DOI: 10.3390/biology13060431.
The Role of Complement Dysregulation in Glaucoma.
Hoppe C, Gregory-Ksander M Int J Mol Sci. 2024; 25(4).
PMID: 38396986 PMC: 10888626. DOI: 10.3390/ijms25042307.
Tang A, Zhao X, Tao T, Xie D, Xu B, Huang Y Front Immunol. 2023; 14:1229806.
PMID: 37781380 PMC: 10540768. DOI: 10.3389/fimmu.2023.1229806.
Complement C6 deficiency exacerbates pathophysiology after spinal cord injury.
Su D, Hooshmand M, Galvan M, Nishi R, Cummings B, Anderson A Sci Rep. 2020; 10(1):19500.
PMID: 33177623 PMC: 7659012. DOI: 10.1038/s41598-020-76441-3.
Reinehr S, Gomes S, Gassel C, Asaad M, Stute G, Schargus M Front Pharmacol. 2019; 10:1381.
PMID: 31849650 PMC: 6901014. DOI: 10.3389/fphar.2019.01381.